Enovis Corp (ENOV) Stock Price, Quote & News

Company Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company's Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic sho...

Industry: Medical Devices

Sector: Healthcare

Phone: 302 252 9160

Website: www.enovis.com

Address:

2711 Centerville Road, Suite 400, Wilmington, United States

OpenOutcrier Jul. 17 at 8:01 PM

RECAP 7/17 +Pos Comments: $FAST + Josh Brown RECAP 7/17 -Neg Comments: $ENOV - Jehosephat $CLSD - Citizens JMP $WFC - Phillip Securities Live Breaking trading news www.openoutcrier.com

0 · Reply

DonCorleone77 Jul. 17 at 1:49 PM

$ENOV You can look up Jehoshaphat (short-seller): Jehoshaphat announces new short position in Enovis

0 · Reply

StockHunter75 Jul. 16 at 7:22 PM

$ENOV Bullish 🐂

0 · Reply

jcmission Jul. 16 at 4:01 PM

$ENOV Bought at 30

0 · Reply

StockHunter75 Jul. 16 at 2:24 PM

$ENOV it's bottomed out and it's a perfect time to add a long position.

0 · Reply

StockHunter75 Jul. 16 at 2:09 PM

$ENOV buying more.

0 · Reply

StockHunter75 Jul. 15 at 2:29 PM

$ENOV no worries shorts will have to cover or burn.

0 · Reply

StockHunter75 Jul. 15 at 1:39 PM

$ENOV buying the dip.

0 · Reply

JarvisFlow Jul. 8 at 1:01 PM

Evercore ISI Group has updated their rating for Enovis ( $ENOV ) to Outperform with a price target of 46.

0 · Reply

DCRMIA Jun. 6 at 4:36 PM

$ENOV Extremely bullish 🎈🎈

0 · Reply

Enovis to Host Second Quarter 2025 Results Conference Call on August 7th

Jun 6, 2025, 4:05 PM EDT - 5 weeks ago

Enovis to Participate in Upcoming Investor Conferences

May 26, 2025, 10:46 AM EDT - 7 weeks ago

Orthopedic Braces & Supports Market Focused Insights 2025-2030, with Key Vendor Profiles for BREG, Bauerfeind, DeRoyals, Enovis, Ottobock, Ossur and Tynor

May 11, 2025, 1:46 AM EDT - 2 months ago

Enovis Corporation (ENOV) Q1 2025 Earnings Call Transcript

May 8, 2025, 6:00 AM EDT - 2 months ago

Enovis Announces First Quarter 2025 Results

Apr 17, 2025, 7:00 AM EDT - 3 months ago

Enovis to Host First Quarter 2025 Results Conference Call on May 8th

Apr 2, 2025, 6:30 AM EDT - 3 months ago

Enovis Announces Appointment of Damien McDonald as Chief Executive Officer

Mar 25, 2025, 8:00 AM EDT - 4 months ago

Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025

Feb 28, 2025, 8:23 AM EST - 4 months ago

Enovis Continues To Languish Despite Decent Financial Results

Feb 26, 2025, 12:53 PM EST - 5 months ago

Enovis Corporation (ENOV) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 6:01 AM EST - 5 months ago

Enovis Announces Fourth Quarter and Full Year 2024 Results

Feb 26, 2025, 6:00 AM EST - 5 months ago

Enovis Announces Planned CEO Succession Process

Jan 17, 2025, 6:00 AM EST - 6 months ago

Enovis™ Announces Leadership Change to International Surgical Business

Jan 7, 2025, 6:19 PM EST - 6 months ago

Maplebear Set to Join S&P MidCap 400; Enovis to Join S&P SmallCap 600

Jan 6, 2025, 4:15 PM EST - 6 months ago

Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Nov 22, 2024, 12:17 PM EST - 8 months ago

Enovis Corporation: Reasonably Valued With Caveats

Nov 6, 2024, 12:50 PM EST - 9 months ago

Enovis Corporation (ENOV) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 6:00 AM EST - 9 months ago

Enovis Announces Third Quarter 2024 Results

Oct 10, 2024, 7:00 AM EDT - 10 months ago

Enovis to Host Third Quarter 2024 Results Conference Call on November 6th

Oct 3, 2024, 3:39 PM EDT - 10 months ago

Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says

Sep 9, 2024, 3:50 PM EDT - 11 months ago

Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies

Aug 20, 2024, 8:00 AM EDT - 11 months ago

Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures

Aug 19, 2024, 8:00 AM EDT - 11 months ago

Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability

Aug 7, 2024, 6:00 AM EDT - 1 year ago

Enovis Announces Second Quarter 2024 Results

Jul 25, 2024, 6:00 AM EDT - 1 year ago

Enovis Announces Time Change for Second Quarter 2024 Results Conference Call

Jul 16, 2024, 7:00 AM EDT - 1 year ago

Enovis to Host Second Quarter 2024 Results Conference Call on August 7th

Jul 15, 2024, 12:58 AM EDT - 1 year ago

Enovis Languishing Despite Respectable Performance

Jul 12, 2024, 8:00 AM EDT - 1 year ago

Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®

Jun 21, 2024, 8:22 AM EDT - 1 year ago

Top 3 Health Care Stocks That Could Blast Off In June

PEN RGEN

May 2, 2024, 2:24 PM EDT - 1 year ago

Enovis Corporation (ENOV) Q1 2024 Earnings Call Transcript

May 2, 2024, 6:00 AM EDT - 1 year ago

Enovis Announces First Quarter 2024 Results

Apr 17, 2024, 7:00 AM EDT - 1 year ago

Enovis to Host First Quarter 2024 Results Conference Call on May 2nd

Feb 22, 2024, 12:14 PM EST - 1 year ago

Enovis Corporation (ENOV) Q4 2023 Earnings Call Transcript

Feb 22, 2024, 6:00 AM EST - 1 year ago

Enovis Announces Fourth Quarter and Full Year 2023 Results

Feb 12, 2024, 11:30 AM EST - 1 year ago

Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting

Feb 7, 2024, 4:15 PM EST - 1 year ago

Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Jan 26, 2024, 6:00 AM EST - 1 year ago

Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd

Jan 25, 2024, 8:30 AM EST - 1 year ago

Enovis Introduces the DonJoy ROAM™ OA Knee Brace

Jan 3, 2024, 6:00 AM EST - 1 year ago

Enovis Completes Acquisition of LimaCorporate S.p.A

Dec 28, 2023, 5:00 AM EST - 1 year ago

Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Dec 5, 2023, 6:00 AM EST - 1 year ago

Enovis Announces Business Segment Leadership Transition Plan

Nov 16, 2023, 4:15 PM EST - 1 year ago

Enovis to participate in the 6th Annual EverCore ISI HealthCONx Conference

Nov 7, 2023, 11:32 AM EST - 1 year ago

Enovis Corporation (ENOV) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 6:00 AM EST - 1 year ago

Enovis Announces Third Quarter 2023 Results and Raises Full-Year Outlook

Oct 20, 2023, 6:00 AM EDT - 1 year ago

ENOVIS CORPORATION ANNOUNCES PRICING OF PRIVATE OFFERING OF $400 MILLION OF 3.875% CONVERTIBLE SENIOR NOTES DUE 2028

Oct 19, 2023, 6:58 AM EDT - 1 year ago

Enovis Corporation Releases Preliminary Information About Its Performance for the Third Quarter 2023

Oct 19, 2023, 6:51 AM EDT - 1 year ago

Enovis Corporation Announces Proposed Private Offering of $400 Million of Convertible Senior Notes

Oct 16, 2023, 7:00 AM EDT - 1 year ago

Enovis to Host Third Quarter 2023 Results Conference Call on November 7th

Sep 27, 2023, 1:23 PM EDT - 1 year ago

Enovis Making Good Choices, But Not Seeing The Rewards

Sep 25, 2023, 6:14 AM EDT - 1 year ago

Enovis to acquire implant maker LimaCorporate for 800 million euros in cash and stock

OpenOutcrier Jul. 17 at 8:01 PM

RECAP 7/17 +Pos Comments: $FAST + Josh Brown RECAP 7/17 -Neg Comments: $ENOV - Jehosephat $CLSD - Citizens JMP $WFC - Phillip Securities Live Breaking trading news www.openoutcrier.com

0 · Reply

DonCorleone77 Jul. 17 at 1:49 PM

$ENOV You can look up Jehoshaphat (short-seller): Jehoshaphat announces new short position in Enovis

0 · Reply

StockHunter75 Jul. 16 at 7:22 PM

$ENOV Bullish 🐂

0 · Reply

jcmission Jul. 16 at 4:01 PM

$ENOV Bought at 30

0 · Reply

StockHunter75 Jul. 16 at 2:24 PM

$ENOV it's bottomed out and it's a perfect time to add a long position.

0 · Reply

StockHunter75 Jul. 16 at 2:09 PM

$ENOV buying more.

0 · Reply

StockHunter75 Jul. 15 at 2:29 PM

$ENOV no worries shorts will have to cover or burn.

0 · Reply

StockHunter75 Jul. 15 at 1:39 PM

$ENOV buying the dip.

0 · Reply

JarvisFlow Jul. 8 at 1:01 PM

Evercore ISI Group has updated their rating for Enovis ( $ENOV ) to Outperform with a price target of 46.

0 · Reply

DCRMIA Jun. 6 at 4:36 PM

$ENOV Extremely bullish 🎈🎈

0 · Reply

JarvisFlow May. 14 at 3:43 PM

Canaccord Genuity updates rating for Enovis ( $ENOV ) to Buy, target set at 75 → 70.

0 · Reply

JarvisFlow May. 9 at 10:30 AM

Needham has updated their rating for Enovis ( $ENOV ) to Buy with a price target of 57.

0 · Reply

LewisDaKat May. 8 at 9:55 PM

$ENOV News out Enovis Announces First Quarter 2025 Results https://marketwirenews.com/news-releases/enovis-announces-first-quarter-2025-results-7987892289471101.html $ENOV

0 · Reply

Estimize May. 8 at 2:06 PM

$ENOV reported 0.81 EPS and 558.83 revenue for Q1. http://www.estimize.com/intro/enov?chart=historical&metric_name=eps&utm_content=ENOV&utm

0 · Reply

DonCorleone77 May. 8 at 10:09 AM

$ENOV Enovis lowers 2025 adjusted EPS view to $2.95-$3.10 from $3.10-$3.25 Consensus for 2025 EPS is $3.18. Raises 2025 revenue view to $$2.22B-$2.25B from $2.19B-$2.22B, consensus $2.21B. Lowers 2025 adjusted EBITDA forecast to $385M-$395M vs. prior outlook of $405M-$415M, and now includes $20M of tariff related impact.

0 · Reply

DonCorleone77 May. 8 at 10:05 AM

$ENOV Enovis reports Q1 adjusted EPS 81c, consensus 74c Reports Q1 revenue $559M, consensus $558.9M. "We delivered a strong start to 2025, with first-quarter revenues and margins exceeding expectations," said CEO Matt Trerotola. "This performance reflects the strength of our business system and the discipline of our teams as we navigate a complex global environment. As we move forward, we remain focused on driving above-market growth through disciplined execution, strategic investment, and a multi-year cadence of high-impact product launches across our portfolio."

0 · Reply

Armonica423 May. 6 at 12:46 PM

$ENOV CYDY

0 · Reply

JarvisFlow Apr. 9 at 1:03 PM

Needham updates rating for Enovis ( $ENOV ) to Buy, target set at 64.

0 · Reply

JarvisFlow Apr. 2 at 4:12 PM

Needham has updated their rating for Enovis ( $ENOV ) to Buy with a price target of 64.

0 · Reply

DonCorleone77 Apr. 2 at 10:58 AM

$ENOV $LIVN Enovis names Damien McDonald as CEO, succeeding Matt Trerotola Enovis (ENOV) announced the appointment of Damien McDonald as CEO, effective May 12. McDonald will also join the Enovis Board of Directors following the conclusion of the company's 2025 Annual Meeting of Stockholders on May 21. He will succeed Matt Trerotola, who previously announced his intention to retire as CEO and has informed the Board that he will not stand for re-election at the Annual Meeting. McDonald joins Enovis with more than 35 years of experience in the medical device industry. Most recently, he served as CEO of LivaNova (LIVN).

0 · Reply

NVDAMillionaire Mar. 26 at 6:26 PM

$ENOV Digging the Lima acquisition play. Recon segment looking strong with 59% global revenue growth. Eyeing their innovation pipeline - shoulder, knee solutions could be game changers. Might start building a position here. notable article: https://beyondspx.com/article/enovis-corporation-enov-a-steadfast-medtech-leader-driving-innovation-and-growth

0 · Reply

SentimentTraderXX Mar. 13 at 1:01 PM

$ENOV accumulating

0 · Reply

Market Cap	1.74B
Revenue (ttm)	2.11B
Net Income (ttm)	-825.49M
EPS (ttm)	N/A
PE Ratio	9.84
Forward PE	10.16
Profit Margin	-39.17%
Debt to Equity Ratio	0.53

Volume	3,333,600
Avg Vol	1,436,082
Day's Range	N/A - N/A
Shares Out	57.12M
Stochastic %K	16%
Beta	1.70
Analysts	Strong Sell
Price Target	$56.30